Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fabian Maximilian Meinert"'
Autor:
Franziska Cygon, Dietger Niederwieser, Lars H. Lindner, Klaus Heißner, Annegret Kunitz, Alexander Stein, Regine Mayer-Steinacker, Jörg Steighardt, Fabian Maximilian Meinert, Ekkehard Eigendorff, Hans-Joachim Schmoll, Bernd Kasper, Hans-Georg Kopp, Torsten Kessler, Gerlinde Egerer, Iver Petersen, Jörn Rüssel, Peter Reichardt, Martina Crysandt
Publikováno v:
JAMA Oncol
Importance Pazopanib and gemcitabine have shown good tolerability, albeit modest single-agent activity in pretreated soft tissue sarcoma. A combined regimen to improve outcomes is required. Objective To determine the efficacy of gemcitabine and pazop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf1f090ef432f0cfe2759e2648037f0
https://pubmed.ncbi.nlm.nih.gov/33355646
https://pubmed.ncbi.nlm.nih.gov/33355646
Autor:
Carla Hannig, Alexander Stein, Axel Florschütz, Fabian Maximilian Meinert, H.-J. Schmoll, Arndt Vogel, Christian Junghanß, Stephan Kanzler, Franziska Cygon, Ulrich Kaiser, Benjamin Garlipp
Publikováno v:
Annals of Oncology. 29:v108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a97c521aecebcb1373409c1087fbe32
https://doi.org/10.1093/annonc/mdy149.022
https://doi.org/10.1093/annonc/mdy149.022
Autor:
Fabian Maximilian Meinert, Axel Florschütz, Ulrich Kaiser, Thomas Edelmann, Christian Junghanß, Michael Schaefers, Bert Hildebrandt, Thomas Göhler, Jörg Steighardt, Stephan Kanzler, Carla Hannig, Arndt Vogel, Alexander Stein, Heinz-Gert Hoeffkes, Hans-Joachim Schmoll, Jörn Rüssel, Benjamin Garlipp, Franziska Cygon, Helmut Forstbauer, Malte Leithäuser
Publikováno v:
Annals of Oncology. 28:iii152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80c7742d220696d2adf7ad6e903ef8e0
https://doi.org/10.1093/annonc/mdx302.006
https://doi.org/10.1093/annonc/mdx302.006
Autor:
Hans-Joachim Schmoll, Bert Hildebrandt, Stephan Kanzler, Ulrich Kaiser, Axel Florschütz, Jörg Steighardt, Alexander Stein, Heinz-Gert Hoeffkes, Thomas Edelmann, Michael Schaefers, Thomas Goehler, Carla Hannig, Fabian Maximilian Meinert, Arndt Vogel, Franziska Cygon, Helmut Forstbauer, Malte Leithäuser, Jörn Rüssel, Christian Junghanss, Benjamin Garlipp
Publikováno v:
Journal of Clinical Oncology. 35:3533-3533
3533 Background: FOLFOXIRI/Bevacizumab (Bev) is superior to FOLFIRI/Bev in the TRIBE trial (F Loupakis, NEJM 2014). The CHARTA trial was developed parallel to TRIBE with the same 4-drug-protocol but vs. FOLFOX/B ev as control arm. Methods: From 7/11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aca22bdd32d1fb1a606446b72ca3fafb
https://doi.org/10.1200/jco.2017.35.15_suppl.3533
https://doi.org/10.1200/jco.2017.35.15_suppl.3533
Autor:
Fabian Maximilian Meinert, Frank Steinbach, Franziska Cygon, Florian Seseke, Hans-Joachim Schmoll, T. Kegel, Khaled Hammad
Publikováno v:
Web of Science
4552 Background: High-dose chemotherapy (HD-CTx) is an active option for salvage chemotherapy in patients (pts) with refractory or relapsed GCT. All previous trials with HD-CTx used one or two cycles of high dose chemotherapy (CTx) including 2 or a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d369a5d2499ad9b82cca41d3bc1da0d5
https://doi.org/10.1200/jco.2017.35.15_suppl.4552
https://doi.org/10.1200/jco.2017.35.15_suppl.4552
Autor:
Fabian Maximilian Meinert, Christian Junghanss, Carla Hannig, Malte Leithaeuser, Stephan Kanzler, Axel Florschütz, Thomas Goehler, Thomas Edelmann, Franziska Cygon, Helmut Forstbauer, Bert Hildebrandt, Jörg Steighardt, Heinz-Gert Hoeffkes, Michael Schaefers, Hans-Joachim Schmoll, Benjamin Garlipp, Alexander Stein, Jörn Rüssel, Arndt Vogel, Ulrich Kaiser
Publikováno v:
Journal of Clinical Oncology. 35:658-658
658 Background: The 4-drug-regimen FOLFOXIRI+Bevacizumab (Bev) was superior to FOLFIRI+Bev (TRIBE F.Loupakis, NEJM 2014). CHARTA investigates the same 4-drug-regimen vs. FOLFOX+Bev. Methods: 250 patients were randomized from 7/11 to 12/14 to standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e165aabf60d8e77a446ec36ab1ddd28
https://doi.org/10.1200/jco.2017.35.4_suppl.658
https://doi.org/10.1200/jco.2017.35.4_suppl.658
Autor:
Stephan Kanzler, J. Ruessel, Carla Hannig, Benjamin Garlipp, H.-J. Schmoll, Thomas Edelmann, M. Schaefers, Heinz-Gert Hoeffkes, Ulrich Kaiser, Thomas Göhler, Fabian Maximilian Meinert, Arndt Vogel, Franziska Cygon, Helmut Forstbauer, Malte Leithäuser, Alexander Stein, Bert Hildebrandt, Axel Florschütz, Jörg Steighardt, Christian Junghanß
Publikováno v:
Annals of Oncology. 27:vi560
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3796055c935680efdc3b2f950433212
https://doi.org/10.1093/annonc/mdw435.14
https://doi.org/10.1093/annonc/mdw435.14